# A Phase I/Ⅱ Clinical Trial for Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Ankylosing Spondylitis

> **NCT07534644** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Shenzhen Huishan Biotechnology Co., Ltd.** · enrollment: 18 (estimated)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **DRUG:** HS_SW01 cells injection

## Key facts

- **NCT ID:** NCT07534644
- **Lead sponsor:** Shenzhen Huishan Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-10
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07534644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07534644, "A Phase I/Ⅱ Clinical Trial for Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Ankylosing Spondylitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07534644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*